Cargando…
One‐year clinical outcome with a novel self‐expanding transcatheter heart valve
OBJECTIVES: To evaluate 1‐year outcome using the ACURATE neo (Symetis S.A., a Boston Scientific Company, Ecublens, Switzerland) according to the updated Valve Academic Research Consortium (VARC‐2) with emphasis on the composite endpoints “clinical efficacy after 30 days” and “time‐related valve safe...
Autores principales: | Pellegrini, Costanza, Rheude, Tobias, Trenkwalder, Teresa, Mayr, N. Patrick, Michel, Jonathan, Kastrati, Adnan, Schunkert, Heribert, Kasel, Albert M., Joner, Michael, Hengstenberg, Christian, Husser, Oliver |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6899934/ https://www.ncbi.nlm.nih.gov/pubmed/30801906 http://dx.doi.org/10.1002/ccd.28144 |
Ejemplares similares
-
Artificial intelligence-enabled phenotyping of patients with severe aortic stenosis: on the recovery of extra-aortic valve cardiac damage after transcatheter aortic valve replacement
por: Lachmann, Mark, et al.
Publicado: (2022) -
One year VARC-2-defined clinical outcomes after transcatheter aortic valve implantation with the SAPIEN 3
por: Pellegrini, Costanza, et al.
Publicado: (2019) -
Comparison of latest generation supra-annular and intra-annular self-expanding transcatheter heart valves
por: Pellegrini, Costanza, et al.
Publicado: (2020) -
Supra‐annular structure assessment for self‐expanding transcatheter heart valve size selection in patients with bicuspid aortic valve
por: Liu, Xianbao, et al.
Publicado: (2018) -
A comparison of valve‐in‐valve transcatheter aortic valve replacement in failed stentless versus stented surgical bioprosthetic aortic valves
por: Choi, Charles H., et al.
Publicado: (2018)